• Captura_de_pantalla_2021-01-24_a_las_12_10_32.png

    New photos of SARS-Cov-2

    24 Jan, 2021


    NIAID’s Rocky Mountain Laboratories (RML) in Hamilton, Montana, produced images of the novel coronavirus (SARS-CoV-2, previously known as 2019-nCoV) on its scanning and transmission electron microscopes on Tuesday, Feb. 11, 2020. SARS-CoV-2 causes COVID-19 disease, which has grown to be a global public health emergency since cases were first detected in Wuhan, China, in December 2019. RML investigator Emmie de Wit, Ph.D., provided the virus samples as part of her studies, microsc...
  • g.PNG

    J&J COVID-19 vaccine could be available in Europe in April: source

    18 Jan, 2021
    Johnson & Johnson could deliver the first doses of its COVID-19 vaccine to Europe in April, an EU official told Reuters on Wednesday after a top lawmaker said the U.S. healthcare company was likely to seek EU regulatory approval in February.
    Clinical data on the vaccine has been assessed by the European Medicines Agency (EMA) since Dec. 1 under a rolling review to speed up possible approval.

    A senior EU official, who is involved in negotiations with vaccine makers and spoke on c...
  • descarga.png

    Immunological characteristics govern the transition of COVID-19 to endemicity

    18 Jan, 2021
    Abstract
    We are currently faced with the question of how the CoV-2 severity may change in the years ahead. Our analysis of immunological and epidemiological data on endemic human coronaviruses (HCoVs) shows that infection-blocking immunity wanes rapidly, but disease-reducing immunity is long-lived. Our model, incorporating these components of immunity, recapitulates both the current severity of CoV-2 and the benign nature of HCoVs, suggesting that once the endemic phase is reached and prim...
  • pp.jpg

    Coronavirus Vaccine Tracker

    18 Jan, 2021








    Vaccines typically require years of research and testing before reaching the clinic, but in 2020, scientists embarked on a race to produce safe and effective coronavirus vaccines in record time. Researchers are currently testing 68 vaccines in clinical trials on humans, and 20 have reached the final stages of testing. At least 90 preclinical vaccines are under active investigation in animals.
    New additions and recent updatesJan. 14The Isr...
  • s9MBwtY2_400x400.png

    Covid-19: Breastfeeding women can have vaccine after guidance turnaround

    11 Jan, 2021

    The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has revised its guidance so that pregnant and breastfeeding women can receive the covid-19 vaccine.

    Writing in BMJ Opinion, Helen Hare, an acute medicine trainee, and Kate Womersley, an academic foundation trainee, said that the change had come after strong pressure from campaigners, clinicians, and some of the women affected.1

    The MHRA had previously recommended that breastfeeding women should not be g...
  • VM3DXLLZ2IHEYMQ5UV3GWJWQVM.jpg

    New coronavirus variant: What do we know?

    4 Jan, 2021




    The rapid spread of a new variant of coronavirus has been blamed for the introduction of strict tier four mixing rules for millions of people, harsher restrictions on mixing at Christmas in England, Scotland and Wales, and other countries placing the UK on a travel ban.


    So how has it gone from being non-existent to the most common form of the virus in parts of England in a matter of months?

    The government's advisers on new infections now say they have "high" ...
  • tfo_logo.png

    Increased expression of hypoxia-induced factor 1α mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients

    28 Dec, 2020
    AbstractBackground
    COVID-19 counts 46 million people infected and killed more than 1.2 million. Hypoxaemia is one of the main clinical manifestations, especially in severe cases. HIF1α is a master transcription factor involved in the cellular response to oxygen levels. The immunopathogenesis of this severe form of COVID-19 is poorly understood.
    Methods
    We performed scRNAseq from leukocytes from five critically ill COVID-19 patients and characterized the expression of hypoxia-inducibl...
  • oglogo.png

    The U.K. Coronavirus Mutation Is Worrying but Not Terrifying

    28 Dec, 2020
    There is evidence the new variant could be more transmissible, yet vaccines work very well against it
    A new mutated form of the novel coronavirus that appears more transmissible than the original has raised alarm in the U.K. and around the world. It does not appear to cause more severe disease, and the newly available vaccines do seem to protect people against it. Yet on December 19—after an announcement that the variant, dubbed B.1.1.7, had suddenly accumulated 17mutations and was spreadi...
    0
  • descarga.png

    Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity

    28 Dec, 2020
    Abstract
    IgG antibodies are crucial for protection against invading pathogens. A highly conserved N-linked glycan within the IgG-Fc tail, essential for IgG function, shows variable composition in humans. Afucosylated IgG variants are already used in anti-cancer therapeutic antibodies for their elevated activity through Fc receptors (FcγRIIIa). Here, we report that afucosylated IgG (~6% of total IgG in humans) are specifically formed against enveloped viruses but generally not against other...
    0
  • Captura_de_pantalla_2020-12-15_a_las_13_10_02.png

    Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets

    6 Dec, 2020
    Abstract



    The coronavirus disease 2019 (COVID-19) pandemic is having a catastrophic impact on human health1. Widespread community transmission has triggered stringent distancing measures with severe socio-economic consequences. Gaining control of the pandemic will depend on the interruption of transmission chains until vaccine-induced or naturally acquired protective herd immunity arises. However, approved antiviral treatments such as remdesivir and reconvalescent serum cannot b...
  • saliva_test.jpg

    New saliva-based antibody test for SARS-COV-2 highly accurate in initial study

    24 Nov, 2020


    The test could prove useful for large-scale screening and epidemiological surveys and cuts down on reliance on blood draws


    A new saliva-based test developed by a team at Johns Hopkins Bloomberg School of Public Health has been found to accurately detect the presence of antibodies to SARS-CoV-2, the virus that causes COVID-19, from small samples of saliva. Such tests, the results of which can be obtained in a matter of hours, are seen as potential alternatives to blood-sampl...
  • proper-mask-wearing.jpg

    Face masks: what the data say

    10 Oct, 2020
    The science supports that face coverings are saving lives during the coronavirus pandemic, and yet the debate trundles on. How much evidence is enough?



    When her Danish colleagues first suggested distributing protective cloth face masks to people in Guinea-Bissau to stem the spread of the coronavirus, Christine Benn wasn’t so sure.

    “I said, ‘Yeah, that might be good, but there’s limited data on whether face masks are actually effective,’” says Benn, a global-health resear...